BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

ACADIA Pharmaceuticals, Inc. 

3911 Sorrento Valley Boulevard

San Diego  California  92121   U.S.A.
Phone: 858-558-2871 Fax: 858-558-2872


SEARCH JOBS

View Clinical Trials from BioPharm Insight




Segment
Drug Discovery

Collaborations

Allergan  Discovery of alpha adrenergic drug candidates that may represent a significant breakthrough in the treatment of neuropathic pain.

Allergan  Develop and commercialize selective muscarinic drugs for the treatment of glaucoma.

Allergan  The third collaboration is designed to leverage ACADIA's R&D platform to discover and develop new therapeutics predominantly in the area of pain.

Sunovion Pharmaceuticals Inc.  ACADIA has formed a broad CNS collaboration with Sepracor for the discovery and development of new drug candidates against muscarinic receptors.





 Company News
ACADIA Pharmaceuticals, Inc. (ACAD) Presents Caregiver Burden Data At The International Congress Of Non-Motor Dysfunctions In Parkinson’s Disease And Related Disorders 12/8/2014 10:45:23 AM
ACADIA Pharmaceuticals, Inc. (ACAD) To Present At Upcoming Investor Conferences 11/25/2014 10:57:29 AM
ACADIA Pharmaceuticals, Inc. (ACAD) To Present At Jefferies and Co. 2014 Global Healthcare Conference On November 20, 2014 11/13/2014 10:55:52 AM
ACADIA Pharmaceuticals, Inc. (ACAD) Reports Third Quarter 2014 Financial Results And Updates Timing Of NUPLAZID™ NDA Submission 11/11/2014 9:11:26 AM
ACADIA Pharmaceuticals, Inc. (ACAD) To Announce Third Quarter 2014 Financial Results On November 10, 2014 11/3/2014 10:09:01 AM
San Diego's ACADIA Pharmaceuticals, Inc. (ACAD) Wins FDA Breakthrough Therapy Designation For NUPLAZID™ 9/2/2014 7:40:24 AM
ACADIA Pharmaceuticals, Inc. (ACAD) Announces Trade Name NUPLAZID™ For Pimavanserin 8/28/2014 11:33:43 AM
ACADIA Pharmaceuticals, Inc. (ACAD) Reports Second Quarter 2014 Financial Results 8/6/2014 9:10:14 AM
ACADIA Pharmaceuticals, Inc. (ACAD) Reports Second Quarter 2014 Financial Results 8/5/2014 2:25:09 PM
ACADIA Pharmaceuticals, Inc. (ACAD) To Announce Second Quarter 2014 Financial Results On August 5, 2014 7/29/2014 9:10:34 AM
12345678910...